Stay updated with breaking news from Present Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EstablishedExclusive Licensing Agreement for CFT8919, an EGFR L858R BiDAC™ Degrader, with Betta Pharmaceuticals in Greater China for NSCLC; U.S. IND Cleared
Imperialism has always been extremely harmful and dangerous, bringing immense distress, death and destruction. However there are at least seven reasons due to
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
Investegate announcements from ITM Isotope Technologies Munic, ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference
PRV111 Patch Topical cancer treatment developed by Privo Technologies PEABODY, Mass. - June 3, 2021 - (Newswire.com) Privo Technologies, Inc. ("Privo"), a biopharmaceutical company focused on optimizing state-of-the-art chemotherapies to be "Tough on cancer, Easy on patients", ann...